GM:NYSEGeneral Motors Company Analysis
Data as of 2026-08-23 - not real-time
$87.93
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At $87.93, General Motors Company shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 12.9%. RSI sits at 58.4, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $83.59 and resistance at $91.85.
The shares look fair at 39.3 times earnings, though no sector average was available for comparison. The average analyst target implies 15.1% above today's level. The 0.82% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 33.2%, a beta of 1.07 and a maximum drawdown of 16.2%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
The shares look fair at 39.3 times earnings, though no sector average was available for comparison. The average analyst target implies 15.1% above today's level. The 0.82% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 33.2%, a beta of 1.07 and a maximum drawdown of 16.2%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
Automotive manufacturer General Motors NYSE:GM reported Q2 CY2026 results , with sales up 1.General Motors NYSE:GM and SAIC Motor agreed to extend their joint venture for another 20 years to deepen cooperation...Earnings results often indicate what direction a company will take in the months ahead.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 79.05
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 79.05
- Analyst targets imply +15.1% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Analyst targets imply +15.1% versus the current price
- P/E ratio of 39.3
- Elevated debt-to-equity of 202
Key Metrics & Analysis
Financial Health
Revenue Growth1.90%
Profit Margin1.05%
P/E Ratio39.3
ROE3.16%
ROA2.25%
Debt/Equity202.34
P/B Ratio1.2
Op. Cash Flow$23.2B
Free Cash Flow$21.9B
Technical Analysis
TrendBullish
RSI58.4
Support$83.59
Resistance$91.85
MA 20$87.40
MA 50$82.14
MA 200$79.05
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair Value$221.89
Target Price$101.19
Upside/Downside15.08%
GradeFair
TypeBlend
Dividend Yield0.82%
Risk Assessment
Beta1.07
Volatility33.21%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.